L Delta B2M Clone 6
DHMi005-A-8
General
Cell Line |
|
hPSCreg name | DHMi005-A-8 |
Cite as: | DHMi005-A-8 |
Alternative name(s) |
L Delta B2M Clone 6
|
Cell line type | Human induced pluripotent stem cell (hiPSC) |
Similar lines |
DHMi005-A-9 (L Delta B2M Clone 11) DHMi005-A (Control_L) IRFMNi001-B-2 (CIone M CIITAKO-B2MKO) RCPCMi007-A-1 (IPSFF1S deltab2m) MUSIi001-A-1 (B2M-KO-SFiPSC5, HLA-I-null SFiPSCs) DHMi005-A-2 (L_FLAG Clone 5) DHMi005-A-3 (L_FLAG Clone 6) DHMi005-A-4 (L_FLAG Clone 7) DHMi005-A-5 (L_mut_FLAG Clone 4) DHMi005-A-1 (L_mut) DHMi005-A-6 (L_mut_FLAG Clone 14) DHMi005-A-7 (L_mut_FLAG Clone 15) |
Last update | 17th November 2023 |
User feedback | |
Provider |
|
Generator | German Heart Center Munich (DHM) |
Owner | German Heart Center Munich, Department of Cardiovascular Surgery, Institute Insure |
Distributors | |
Derivation country | Germany |
External Databases |
|
BioSamples | SAMEA114632708 |
General Information |
|
* Is the cell line readily obtainable for third parties? |
No |
Subclone of |
Donor Information
General Donor Information |
|
Sex | male |
Ethnicity | Caucasian |
Phenotype and Disease related information (Donor) |
|
Diseases | No disease was diagnosed.
|
Family history | No abnormalities have been described with regard to the family history. |
Is the medical history available upon request? | no, healthy proband |
Is clinical information available? | no, healthy proband |
Other Genotyping (Donor) |
|
Is there genome-wide genotyping or functional data available? |
No
|
External Databases (Donor) |
|
BioSamples | SAMEA12738677 |
Ethics
Also have a look at the ethics information for the parental line
DHMi005-A
.
Is there an MTA available for the cell line? | No |
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? | |
Are you aware of any constraints on the use or distribution of the cell line from the owner or any parties identified in the query above? | No |
hIPSC Derivation
General |
|
The source cell information can be found in the parental cell line
DHMi005-A.
|
|
Reprogramming method |
|
Vector type | Non-integrating |
Vector | Sendai virus |
Vector free reprogramming |
|
Other |
|
Derived under xeno-free conditions |
No |
Derived under GMP? |
No |
Available as clinical grade? |
No |
Culture Conditions
Surface coating | Matrigel/Geltrex |
Feeder cells |
No |
Passage method |
Enzyme-free cell dissociation
ReLeSR
|
CO2 Concentration | 5 % |
Medium |
mTeSR™ Plus
|
Has Rock inhibitor (Y27632) been used at passage previously with this cell line? | Yes |
Characterisation
Analysis of Undifferentiated Cells
Differentiation Potency
Microbiology / Virus Screening |
|
Mycoplasma | Negative |
Genotyping
Karyotyping (Cell Line) |
|
Has the cell line karyotype been analysed? |
Yes
46 XY
Passage number: 52
|
Other Genotyping (Cell Line) |
Genetic Modification
Genetic modifications not related to a disease |
|
Login to share your feedback, experiences or results with the research community.